# Syndax Pharmaceuticals, Inc. (SNDX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/SNDX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 64.86M | $ -42.67M | $ -50.35M | $ 345.36M | $ 41.62M |
| 2025 | $ 176.47M | $ -292.25M | $ -330.89M | $ 346.48M | $ 64.63M |
| 2024 | $ 24.89M | $ -335.04M | $ -288.94M | $ 345.74M | $ 288.12M |
| 2023 | $ 0 | $ -226.37M | $ -173.65M | $ 1.64M | $ 554.20M |
| 2022 | $ 0 | $ -166.83M | $ -149.33M | $ 1.16M | $ 467.45M |
| 2021 | $ 166.07M | $ 29.63M | $ 34.47M | $ 20.97M | $ 408.37M |
| 2020 | $ 1.93M | $ -93.20M | $ -90.78M | $ 20.54M | $ 252.19M |
| 2019 | $ 1.96M | $ -72.34M | $ -65.33M | $ 897.0K | $ 31.60M |
| 2018 | $ 2.00M | $ -97.68M | $ -90.76M | $ 0 | $ 53.05M |
| 2017 | $ 2.84M | $ -81.91M | $ -63.93M | $ 0 | $ 104.32M |
| 2016 | $ 1.68M | $ -61.19M | $ -48.73M | $ 0 | $ 84.14M |
| 2015 | $ 880.3K | $ -33.86M | $ -3.48M | $ 0 | $ 66.70M |
| 2014 | $ 1.70M | $ -28.02M | $ -20.34M | $ 13.88M | $ -5.72M |
| 2013 | $ 0 | $ -20.15M | $ -10.43M | $ 0 | $ 11.85M |
| 2012 | $ 0 | $ -3.9K | $ -1.5K | $ 0 | $ -27.5K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 8.30 |
| Liabilities / Eq | 10.36 |
| Current Ratio | 5.47 |

## Other views

- [Metrics](https://sponda.capital/en/SNDX.md)
- [Charts](https://sponda.capital/en/SNDX/charts.md)
- [Compare](https://sponda.capital/en/SNDX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.